Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Jan 28, 2019

SELL
$2.46 - $4.2 $389,479 - $664,965
-158,325 Closed
0 $0
Q3 2018

Oct 11, 2018

BUY
$3.81 - $5.53 $96,488 - $140,047
25,325 Added 19.04%
158,325 $652,000
Q2 2018

Jul 09, 2018

BUY
$5.06 - $6.78 $129,409 - $173,398
25,575 Added 23.81%
133,000 $690,000
Q1 2018

Apr 04, 2018

BUY
$5.43 - $8.36 $583,317 - $898,072
107,425 New
107,425 $589 Million

Others Institutions Holding ENZ

About ENZO BIOCHEM INC


  • Ticker ENZ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 48,720,500
  • Market Cap $26.8M
  • Description
  • Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...
More about ENZ
Track This Portfolio

Track Davenport & CO LLC Portfolio

Follow Davenport & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davenport & CO LLC with notifications on news.